Related Funds
Fund Name | Location |
Clover Holdings Ltd | England, London, United Kingdom |
Dada | Firenze, Italy, Toscana |
East Midlands Business Angels | Newark Upon Trent, Nottinghamshire, United Kingdom |
First Republic Bank | California, San Francisco, United States |
First Republic Capital | Canada, Ontario, Toronto |
Imagination Capital | New York, New York, United States |
Kewpie Corporation | Japan, Minato |
Kingpoint | China, Guangdong, Guangzhou |
MFV Partners | California, Palo Alto, United States |
National Securities Corporation | New York, New York, United States |
Ningbo Mingge Touzi | China, Ningbo, Zhejiang |
NKB Ventures | England, London, United Kingdom |
Omidyar Technology Ventures | California, Redwood City, United States |
Oxford Angel Fund | California, San Francisco, United States |
Ports America | Jersey City, New Jersey, United States |
Upswell Ventures | - |
ValueShine Ventures | Israel, Tel Aviv, Tel Aviv District |
VIA Capital Group | - |
YMC Investment | China, Hangzhou, Zhejiang |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
M-Based | 25 Jul 2024 | - | |||
Ion membranes | $750K | 23 Nov 2023 | Istanbul, Istanbul, Turkey | ||
Evreka | $2M | 06 Jan 2022 | Ankara, Ankara, Turkey | ||
MOBIQU | $250K | 03 Nov 2021 | Istanbul, Istanbul, Turkey | ||
Inofab Health | $1M | 06 Jan 2021 | Ankara, Ankara, Turkey | ||
Inofab Health | 01 Jun 2020 | Ankara, Ankara, Turkey |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
M-Based | 25 Jul 2024 | - | |||
Ion membranes | $750K | 23 Nov 2023 | Istanbul, Istanbul, Turkey | ||
Evreka | $2M | 06 Jan 2022 | Ankara, Ankara, Turkey | ||
MOBIQU | $250K | 03 Nov 2021 | Istanbul, Istanbul, Turkey | ||
Inofab Health | $1M | 06 Jan 2021 | Ankara, Ankara, Turkey | ||
Inofab Health | 01 Jun 2020 | Ankara, Ankara, Turkey |